Hologic has expanded the sales region of the Novodiag molecular diagnostic system to encompass a broader range of customers within Europe after it acquired Novodag's developer, Mobidiag.
Hologic announced plans to acquire the Finland-based molecular diagnostic company for $795m in April. The deal closed in June. (Also see "Hologic Continues 2021 Spending Spree With $795M Acquisition...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?